IntraLogisteX USA: October 22nd and October 23rd, 2024 – Miami Beach Convention Center,
Audience Quality And Quantity Is Assured At IntraLogistex USA – The Number One Exhibition For…
Logistics
BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II
SUNNYVALE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular…
BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II
SUNNYVALE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular…
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus…
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus…
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus
QuantiFERON-EBV RUO to help researchers understand Epstein-Barr virus (EBV) infections and related malignancies, offering a…
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platform WOBURN, Mass., Oct. 03, 2023…
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platform WOBURN, Mass., Oct. 03, 2023…
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform…
Outlook Therapeutics® Requests Type A Meeting With FDA
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
Outlook Therapeutics® Requests Type A Meeting With FDA
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified…
QIAGEN reports progress toward achieving Environmental, Social and Governance goals in 2022 Sustainability Report
Progress on Environment, Social and Governance (ESG) goals reflected in QIAGEN securing a „Prime“ rating…
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
International certification adds to Quality Management Systems credentials for the medical device industry and supports…
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
International certification adds to Quality Management Systems credentials for the medical device industry and supports…
ProQR Therapeutics Provides Update on Ophthalmic Assets
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
ProQR Therapeutics Provides Update on Ophthalmic Assets
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
Societal CDMO to Participate in RBC Capital Markets Virtual CDMO Conference
SAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal…